121 related articles for article (PubMed ID: 27185639)
1. Discovery of Phosphorylated Peripherin as a Major Humoral Autoantigen in Type 1 Diabetes Mellitus.
Doran TM; Morimoto J; Simanski S; Koesema EJ; Clark LF; Pels K; Stoops SL; Pugliese A; Skyler JS; Kodadek T
Cell Chem Biol; 2016 May; 23(5):618-628. PubMed ID: 27185639
[TBL] [Abstract][Full Text] [Related]
2. Peripherin is a relevant neuroendocrine autoantigen recognized by islet-infiltrating B lymphocytes.
Puertas MC; Carrillo J; Pastor X; Ampudia RM; Planas R; Alba A; Bruno R; Pujol-Borrell R; Estanyol JM; Vives-Pi M; Verdaguer J
J Immunol; 2007 May; 178(10):6533-9. PubMed ID: 17475883
[TBL] [Abstract][Full Text] [Related]
3. Discovery of native autoantigens via antigen surrogate technology: application to type 1 diabetes.
Doran TM; Simanski S; Kodadek T
ACS Chem Biol; 2015 Feb; 10(2):401-12. PubMed ID: 25474415
[TBL] [Abstract][Full Text] [Related]
4. Role of humoral beta-cell autoimmunity in type 1 diabetes.
Knip M; Siljander H; Ilonen J; Simell O; Veijola R
Pediatr Diabetes; 2016 Jul; 17 Suppl 22():17-24. PubMed ID: 27411432
[TBL] [Abstract][Full Text] [Related]
5. Antigenicity and epitope specificity of ZnT8 autoantibodies in type 1 diabetes.
Skärstrand H; Lernmark A; Vaziri-Sani F
Scand J Immunol; 2013 Jan; 77(1):21-9. PubMed ID: 23126564
[TBL] [Abstract][Full Text] [Related]
6. Peripherin-reactive antibodies in mouse, rabbit, and human blood.
Strom A; Sonier B; Chapman HD; Mojibian M; Wang GS; Slatculescu CR; Serreze DV; Scott FW
J Proteome Res; 2010 Mar; 9(3):1203-8. PubMed ID: 20113007
[TBL] [Abstract][Full Text] [Related]
7. New Players in the Field of T1D: Anti-Peripherin B Lymphocytes.
Kendall PL
Diabetes; 2016 Jul; 65(7):1794-6. PubMed ID: 27329956
[No Abstract] [Full Text] [Related]
8. Serological Proteome Analysis (SERPA) as a tool for the identification of new candidate autoantigens in type 1 diabetes.
Massa O; Alessio M; Russo L; Nardo G; Bonetto V; Bertuzzi F; Paladini A; Iafusco D; Patera P; Federici G; Not T; Tiberti C; Bonfanti R; Barbetti F
J Proteomics; 2013 Apr; 82():263-73. PubMed ID: 23500132
[TBL] [Abstract][Full Text] [Related]
9. Vasostatin-1 antigenic epitope mapping for induction of cellular and humoral immune responses to chromogranin A autoantigen in NOD mice.
Nikoopour E; Cheung R; Bellemore S; Krougly O; Lee-Chan E; Stridsberg M; Singh B
Eur J Immunol; 2014 Apr; 44(4):1170-80. PubMed ID: 24443235
[TBL] [Abstract][Full Text] [Related]
10. The Evolving Landscape of Autoantigen Discovery and Characterization in Type 1 Diabetes.
Purcell AW; Sechi S; DiLorenzo TP
Diabetes; 2019 May; 68(5):879-886. PubMed ID: 31010879
[TBL] [Abstract][Full Text] [Related]
11. Glutamic acid decarboxylase autoantibodies in stiff-man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition.
Daw K; Ujihara N; Atkinson M; Powers AC
J Immunol; 1996 Jan; 156(2):818-25. PubMed ID: 8543838
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the humoral immune response to islet antigen 2 in children with newly diagnosed type 1 diabetes.
Mäkinen A; Härkönen T; Ilonen J; Knip M;
Eur J Endocrinol; 2008 Jul; 159(1):19-26. PubMed ID: 18573919
[TBL] [Abstract][Full Text] [Related]
13. Importin beta: a novel autoantigen in human autoimmunity identified by screening random peptide libraries on phage.
Ola TO; Biro PA; Hawa MI; Ludvigsson J; Locatelli M; Puglisi MA; Bottazzo GF; Fierabracci A
J Autoimmun; 2006 May; 26(3):197-207. PubMed ID: 16549322
[TBL] [Abstract][Full Text] [Related]
14. Serological autoantibody profiling of type 1 diabetes by protein arrays.
Miersch S; Bian X; Wallstrom G; Sibani S; Logvinenko T; Wasserfall CH; Schatz D; Atkinson M; Qiu J; LaBaer J
J Proteomics; 2013 Dec; 94():486-96. PubMed ID: 24148850
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune mechanisms in type 1 diabetes.
Knip M; Siljander H
Autoimmun Rev; 2008 Jul; 7(7):550-7. PubMed ID: 18625444
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic islet autoimmunity.
Boitard C
Presse Med; 2012 Dec; 41(12 P 2):e636-50. PubMed ID: 23182678
[TBL] [Abstract][Full Text] [Related]
17. Mycobacterial Hsp65 potentially cross-reacts with autoantibodies of diabetes sera and also induces (in vitro) cytokine responses relevant to diabetes mellitus.
Rani PS; Babajan B; Tulsian NK; Begum M; Kumar A; Ahmed N
Mol Biosyst; 2013 Nov; 9(11):2932-41. PubMed ID: 24056978
[TBL] [Abstract][Full Text] [Related]
18. IA-2 (islet cell antigen 512) is the primary target of humoral autoimmunity against type 1 diabetes-associated tyrosine phosphatase autoantigens.
Bonifacio E; Lampasona V; Bingley PJ
J Immunol; 1998 Sep; 161(5):2648-54. PubMed ID: 9725268
[TBL] [Abstract][Full Text] [Related]
19. Relation among mannose-binding lectin 2 genotype, beta-cell autoantibodies, and risk for type 1 diabetes in Finnish children.
Aittoniemi J; Turpeinen H; Tiittanen M; Knip M; Simell O; Ilonen J; Vaarala O
Hum Immunol; 2008 Feb; 69(2):108-11. PubMed ID: 18361935
[TBL] [Abstract][Full Text] [Related]
20. Endogenous ecotropic murine leukemia viral (MuLV) envelope protein as a new autoantigen reactive with non-obese diabetic mice sera.
Choi SE; Kim KS; Kim KH; Choi UY; Kim HM; Yoon JW; Kang Y
J Autoimmun; 2000 Nov; 15(3):347-57. PubMed ID: 11040075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
